Bioequivalence testing of Glivec generic likely to be made compulsory

Published: 2010-06-07 06:59:00
Updated: 2010-06-07 06:59:00
Drugmakers who intends to produce the generic version of Glivec (imatinib mesylate) will be required to conduct equivalence testing over patients instead of healthy volunteers.

“It must be necessary for pharmaceutical manufacturers to reassess the safety and efficacy of Glivec generics in canc...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.